Does DARATUMUMAB Cause Supraventricular tachycardia? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Supraventricular tachycardia have been filed in association with DARATUMUMAB (DARZALEX). This represents 0.1% of all adverse event reports for DARATUMUMAB.
18
Reports of Supraventricular tachycardia with DARATUMUMAB
0.1%
of all DARATUMUMAB reports
2
Deaths
8
Hospitalizations
How Dangerous Is Supraventricular tachycardia From DARATUMUMAB?
Of the 18 reports, 2 (11.1%) resulted in death, 8 (44.4%) required hospitalization, and 3 (16.7%) were considered life-threatening.
Is Supraventricular tachycardia Listed in the Official Label?
Yes, Supraventricular tachycardia is listed as a known adverse reaction in the official FDA drug label for DARATUMUMAB.
What Other Side Effects Does DARATUMUMAB Cause?
Plasma cell myeloma (2,980)
Infusion related reaction (2,557)
Off label use (2,494)
Pneumonia (1,450)
Neutropenia (1,351)
Drug ineffective (1,110)
Thrombocytopenia (1,089)
Death (1,088)
Pyrexia (1,032)
Dyspnoea (996)
What Other Drugs Cause Supraventricular tachycardia?
ADALIMUMAB (141)
METOPROLOL (132)
ROSIGLITAZONE (114)
TREPROSTINIL (113)
RITUXIMAB (99)
ALBUTEROL (98)
IBRUTINIB (96)
DEXAMETHASONE (95)
ASPIRIN (92)
LEVOTHYROXINE (91)
Which DARATUMUMAB Alternatives Have Lower Supraventricular tachycardia Risk?
DARATUMUMAB vs DARATUMUMAB\HYALURONIDASE-FIHJ
DARATUMUMAB vs DARBEPOETIN ALFA
DARATUMUMAB vs DARIDOREXANT
DARATUMUMAB vs DARIFENACIN HYDROBROMIDE
DARATUMUMAB vs DAROLUTAMIDE